TREM2 promotes the optimal microglial function required to attenuate disease progression and is a potential target for eliciting a protective role of microglia in Alzheimer’s disease and other neurodegenerative diseases (8). Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.